BreatheIN: Realising the Clinical Potential of Oligonucleotide Rx for Respiratory Disease

Sterghios Moschos

Research output: Contribution to conference › Other › peer-review

Original language	English
Publication status	Published - 1 Feb 2017
Event	MedImmune & AstraZeneca joint presentation - Cambridge, United Kingdom Duration: 1 Feb 2017 → 1 Feb 2017

Seminar	MedImmune & AstraZeneca joint presentation
Country/Territory	United Kingdom
City	Cambridge
Period	1/02/17 → 1/02/17

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{4a4650e3796f4f1a913b5c0b98796a9f,

title = "BreatheIN: Realising the Clinical Potential of Oligonucleotide Rx for Respiratory Disease",

author = "Sterghios Moschos",

year = "2017",

month = feb,

day = "1",

language = "English",

note = "MedImmune & AstraZeneca joint presentation ; Conference date: 01-02-2017 Through 01-02-2017",

}